End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.47 CNY | -3.17% |
|
+14.51% | -19.27% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.27% | 177.85Cr | |
+25.40% | 4.53TCr | |
+38.38% | 2.43TCr | |
+27.09% | 1.65TCr | |
+21.19% | 1.46TCr | |
+71.91% | 1.43TCr | |
-0.05% | 678.76Cr | |
-11.63% | 656.86Cr | |
+15.08% | 576.04Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- HighTide Therapeutics, Inc. announced that it expects to receive CNY 79 million in funding from Shenzhen Hepalink Pharmaceutical Group Co., Ltd.